ABT - Abbott Laboratories
(NaN%)
SNP 500
Sell
Moderate Growth but Declining●Stock Price Very High
57%
based on last 5 year data.
Income Statement is MODERATE
Revenue Growth is 3.15%
Operating Income Growth is 11.53%
Net Income Growth is 11.71%
Earnings Per Share (EPS) Growth is 11.9%
Net Margin is 13.94%
Balance Sheet is MODERATE
Current Asset to Current Liability Ratio is 1.6
Debt Ratio is 0.2
Current Debt to Net Income Ratio is 1.31
Total Debt to Total Assets Ratio is 0.2
Cash Flow is STRONG
Cash from Operations Growth is 33.27%
Capital Expenditure is High
Net Increase in Cash is Positive
Long Term Score Trend is NEGATIVE
Investment Risk is High
based on last 4 quarter data.
Better viewed in landscape mode.
Unless specified, all values are in USD Millions. Data extracted from SEC Filing and are subject to processing and input errors.
Abbott Laboratories (ABT) - https://www.abbott.com/
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States.Exchange - NEW YORK STOCK EXCHANGE INC.
Industry - Surgical and Medical Instrument Manufacturing
Sector - Manufacturing
CEO -
Employees - 115,000
Disclaimer - Investment in securities involves substantial risk and could result in significant loss. It is not suitable for every investor. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser. We may own some of the securities mentioned in this website.
Know the Stock © 2024 and future.
Know the Stock © 2024 and future.